Department of Medicine, Division of Pulmonary and Critical Care, Stanford University, Stanford, California, USA.
Department of Medicine, Quantitative Sciences Unit, Stanford University, Stanford, California, USA.
J Heart Lung Transplant. 2018 Mar;37(3):394-400. doi: 10.1016/j.healun.2017.09.017. Epub 2017 Sep 30.
The United States lung transplant registry data demonstrate differences in adult waitlist mortality by race/ethnicity. It is unknown whether these differences persist after risk adjustment or occur secondary to disparities in disease severity at the time of listing.
Adult lung transplant waitlist candidates between May 4, 2005 and March 5, 2015 were identified and compared by non-Hispanic white (NHW), non-Hispanic black (NHB), Hispanic and Asian race/ethnicity. A competing risk proportional hazards model was used to assess the association of race/ethnicity with the unadjusted and adjusted risk of waitlist death or removal for too sick, transplant, or removal for other reason. Disease illness severity at transplant listing was compared by race/ethnicity.
There were 20,684 lung transplant candidates identified (82% NHW, 9% NHB, 6% Hispanic, 2% Asian and 1% other). Non-white candidates had higher unadjusted waitlist mortality, which was fully mitigated by adjusting for other risk factors (NHB: hazard ratio [HR] 1.05, 95% confidence interval [CI] 0.93 to 1.18; Hispanic: HR 1.02, 95% CI 0.99 to 1.18; Asian: HR 0.90, 95% CI 0.70 to 1.16). Adjusted waitlist access to transplant was lower in non-white candidates (NHB: HR 0.88, 95% CI 0.83 to 0.94; Hispanic: HR 0.87, 95% CI 0.81 to 0.94; Asian: HR 0.83, 95% CI 0.73 to 0.96). NHW candidates with obstructive lung disease and pulmonary fibrosis were older with less illness severity at listing than non-white candidates.
Within the current lung allocation system, there is no difference in risk-adjusted waitlist mortality by race/ethnicity, but non-white waitlist candidates have lower risk-adjusted access to lung transplant. Non-white candidates are generally younger with greater disease-specific illness severity at the time of lung transplant listing.
美国肺移植登记数据显示,不同种族/族裔的成年候补者死亡率存在差异。尚不清楚这些差异在风险调整后是否仍然存在,或者是否是由于在列入名单时疾病严重程度的差异所致。
2005 年 5 月 4 日至 2015 年 3 月 5 日期间,确定了成年肺移植候补者,并按非西班牙裔白人(NHW)、非西班牙裔黑人(NHB)、西班牙裔和亚裔进行比较。使用竞争风险比例风险模型评估种族/族裔与未调整和调整后的候补者死亡或因病情太重而被移除、移植或因其他原因被移除的风险之间的关联。按种族/族裔比较移植时的疾病严重程度。
共确定了 20684 名肺移植候选者(82%为 NHW,9%为 NHB,6%为西班牙裔,2%为亚裔,1%为其他)。非白人选民的未调整候补者死亡率较高,但通过调整其他风险因素,该死亡率得到完全缓解(NHB:风险比[HR]1.05,95%置信区间[CI]0.93 至 1.18;西班牙裔:HR1.02,95%CI0.99 至 1.18;亚裔:HR0.90,95%CI0.70 至 1.16)。非白人选民调整后的候补者获得移植的机会较低(NHB:HR0.88,95%CI0.83 至 0.94;西班牙裔:HR0.87,95%CI0.81 至 0.94;亚裔:HR0.83,95%CI0.73 至 0.96)。患有阻塞性肺疾病和肺纤维化的 NHW 候选者年龄较大,在列入名单时疾病严重程度较低。
在当前的肺分配系统中,种族/族裔之间的风险调整候补者死亡率没有差异,但非白人选民调整后的肺移植机会较低。非白人选民在列入肺移植名单时通常年龄较小,疾病特异性疾病严重程度较大。